Nov 7, 2025 03:51AM
Oct 17, 2025 05:05AM
Oct 6, 2025 02:25AM
Sep 25, 2025 03:05AM
Aug 5, 2025 06:02AM
Jul 29, 2025 10:05AM
Jul 28, 2025 02:52AM Barclays Downgrades Sarepta Therapeutics (SRPT) to Underweight
Jul 22, 2025 03:52AM
Jul 16, 2025 12:38PM
Jul 1, 2025 01:02AM
Jun 26, 2025 10:32AM
May 7, 2025 06:00AM
Apr 24, 2025 04:17AM
Apr 4, 2025 12:28PM Barclays Reiterates Overweight Rating on Sarepta Therapeutics (SRPT)
Feb 18, 2025 05:13AM
Nov 5, 2024 05:23AM
Oct 15, 2024 02:15PM
Oct 11, 2024 05:56AM
Oct 4, 2024 07:52AM
Sep 16, 2024 03:08PM
Sep 3, 2024 05:25AM Barclays Reiterates Overweight Rating on Alnylam Pharmaceuticals (ALNY)
Aug 5, 2024 03:25AM
May 21, 2024 06:23AM
May 16, 2024 02:43PM
Apr 15, 2024 04:33AM
Nov 28, 2022 12:53PM
Aug 9, 2022 05:34AM
Apr 18, 2022 07:35AM Barclays Downgrades BioCryst Pharma (BCRX) to Equalweight
Mar 15, 2022 06:40AM
Jun 21, 2021 04:48AM
Mar 9, 2021 05:00AM
Mar 9, 2021 05:01AM
Dec 29, 2020 08:14AM
Nov 4, 2020 07:05AM
Sep 3, 2020 07:05AM uniQure to Participate in Multiple Upcoming Industry Conferences in September
Jun 8, 2020 06:17AM
Feb 18, 2020 07:34AM
Nov 27, 2019 07:04AM
Nov 5, 2019 04:55AM
Nov 5, 2019 04:54AM
Nov 1, 2019 04:31AM
Sep 5, 2019 03:47AM Barclays Starts Orchard Therapeutics (ORTX) at Overweight
Aug 9, 2019 04:22AM
Aug 2, 2019 06:18AM
Apr 22, 2019 12:45AM
Mar 25, 2019 01:46AM
Mar 25, 2019 01:46AM
Feb 28, 2019 04:36PM
Feb 19, 2019 11:24AM Spark Therapeutics (ONCE) PT Lowered to $74 at Barclays
Dec 18, 2018 09:04AM

145 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All